About FDA

DDI Webinar- “Introduction to Post-Marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER”- February 23, 2016

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all healthcare professionals, pharmacy students, nurse practitioner students, physician assistants, and medical students. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!

On February 23, 2016, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: "Introduction to Post-Marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER". The featured speaker was LCDR Monica Muñoz, PharmD, MS, BCPS, Safety Evaluator for FDA’s Division of Pharmacovigilance (DPV). The presentation gave an overview of pharmacovigilance: the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or other drug-related problems.

Presentation Information

Page Last Updated: 04/28/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English